Literature DB >> 3554270

The actions of SCH 23390, a D1 receptor antagonist, on operant and avoidance behavior in rats.

D J Sanger.   

Abstract

Previous studies have shown that dopamine antagonists such as haloperidol, pimozide and metoclopramide will produce gradually increasing decrements of operant and avoidance responding. The present study was carried out to investigate whether the dopamine D1 blocking agent, SCH 23390, would exert a similar effect. In the first experiment, SCH 23390 produced a dose-related (0.03-0.1 mg/kg) reduction in responding maintained by an FR 10 schedule of food reinforcement. However, the compound gave rise to similar reductions of response rate throughout the 15 min session. In a second experiment, higher doses of SCH 23390 (0.1-1.0 mg/kg) disrupted one-way avoidance performance in a shuttle-box. Again, there was no within-session decline in responding after administration of SCH 23390 although injection of a dose of 0.4 mg/kg of haloperidol produced a greater response deficit during the second half of the session. During 4 daily administrations of 0.3 mg/kg of SCH 23390 the degree to which avoidance responding was disrupted neither increased nor decreased. SCH 23390 disrupts operant bar pressing and one-way avoidance responding but its actions in these behavioral tests are not identical to the effects of typical neuroleptics such as haloperidol.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3554270     DOI: 10.1016/0091-3057(87)90157-2

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  7 in total

1.  SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade?

Authors:  E Acquas; E Carboni; P Leone; G Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Long-term treatment with low doses of the D1 antagonist NNC 756 and the D2 antagonist raclopride in monkeys previously exposed to dopamine antagonists.

Authors:  H Lublin; J Gerlach; F Mørkeberg
Journal:  Psychopharmacology (Berl)       Date:  1994-04       Impact factor: 4.530

3.  Effects of systemic or nucleus accumbens-directed dopamine D1 receptor antagonism on sucrose seeking in rats.

Authors:  Jeffrey W Grimm; John H Harkness; Christine Ratliff; Jesse Barnes; Kindsey North; Stefan Collins
Journal:  Psychopharmacology (Berl)       Date:  2011-02-12       Impact factor: 4.530

4.  Synergistic interaction between baclofen administration into the median raphe nucleus and inconsequential visual stimuli on investigatory behavior of rats.

Authors:  Fiori R Vollrath-Smith; Rick Shin; Satoshi Ikemoto
Journal:  Psychopharmacology (Berl)       Date:  2011-09-09       Impact factor: 4.530

5.  Differential effects of the adenosine A₂A agonist CGS-21680 and haloperidol on food-reinforced fixed ratio responding in the rat.

Authors:  Chris Jones-Cage; Thomas R Stratford; David Wirtshafter
Journal:  Psychopharmacology (Berl)       Date:  2011-09-07       Impact factor: 4.530

6.  Chronic treatment with the D1 receptor antagonist, SCH 23390, and the D2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment. Extrapyramidal syndromes and dopaminergic supersensitivity.

Authors:  H Lublin; J Gerlach; L Peacock
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Behavioral and neurochemical characterization of kratom (Mitragyna speciosa) extract.

Authors:  Anne-Christin Stolt; Helmut Schröder; Hartmud Neurath; Gisela Grecksch; Volker Höllt; Markus R Meyer; Hans H Maurer; Nancy Ziebolz; Ursula Havemann-Reinecke; Axel Becker
Journal:  Psychopharmacology (Berl)       Date:  2013-07-12       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.